Pharmaceutical sales in the UK are undergoing a gradual but meaningful shift in who represents medicines to healthcare ...
BioMarin Pharmaceutical Inc. ( BMRN) TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM EST ...
Sanofi is betting $1.53 billion on a novel drug from Sino Biopharmaceutical, securing global rights to a first-in-class JAK/ROCK inhibitor that could play a double role in the French pharma’s ...
SHANGHAI, SHANGHAI, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of industrial automation, ...
A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue ...
NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- Ningbo Qinmeng Maternal and Child Products Co., Ltd., a ...
There's been a flurry of recent activity in the direct-to-consumer space as drug costs and spending continues to rise. | LOS ...
UCB and Antengene enter global license agreement for ATG-201, a B cell-depleting bispecific antibody
UCB obtains worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseasesDeal ...
Dr. Reske has proven leadership in clinical development and regulatory affairs following key role in FDA approval of ...
ZHANGJIAGANG CITY, JIANGSU, CHINA, January 19, 2026 /EINPresswire.com/ -- PET plastic packaging is widely used in the ...
GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...
LIMERICK, Ireland, Feb. 25, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results